ArticleInflammation and regeneration2026

Safety and efficacy profile of S-005151 (Redasemtide), in patients with chronic liver diseases: phase 2 trial.

Atsunori Tsuchiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.